WCVB's Emily Reimer explores Quanterix' next generation Simoa planar array technology.
In The News
WCVB News Boston | February 06, 2019
NECN | January 25, 2019
An overview of Quanterix’ story, detailing our groundbreaking Simoa technology, the process of measuring biomarkers to detect and advance the treatment of disease, as well as the real world applications of how our technology is impacting how health care is practiced.
GenomeWeb/360dx | January 28, 2019
Jan 24, 2019 | Adam Bonislawski
CNN | January 22, 2019
By Nina Avramova, CNN Tue January 22, 2019 (CNN) A simple blood test could predict if a patient will develop Alzheimer's disease up to 16 years before symptoms begin, a new study finds.
Genome Web | January 10, 2019
Jan 10, 2019 | Monica Heger
January 09, 2019
CEO Kevin Hrusovsky wows a packed audience with Quanterix' vision and progress towards transforming healthcare at the 2019 J.P. Morgan Health Conference in San Francisco.
David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
FierceBiotech | November 19, 2018
by Conor Hale
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky